Search by Drug Name or NDC
NDC 42367-0531-33 Pemfexy 25 mg/mL Details
Pemfexy 25 mg/mL
Pemfexy is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eagle Pharmaceuticals, Inc.. The primary component is PEMETREXED MONOHYDRATE.
Product Information
NDC | 42367-0531 |
---|---|
Product ID | 42367-531_041cbcd7-a78a-47bd-8288-0e0b828f6706 |
Associated GPIs | 21300053002030 |
GCN Sequence Number | 075880 |
GCN Sequence Number Description | pemetrexed VIAL 25 MG/ML INTRAVEN |
HIC3 | V1B |
HIC3 Description | ANTINEOPLASTIC - ANTIMETABOLITES |
GCN | 41044 |
HICL Sequence Number | 043305 |
HICL Sequence Number Description | PEMETREXED |
Brand/Generic | Brand |
Proprietary Name | Pemfexy |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | pemetrexed |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 25 |
Active Ingredient Units | mg/mL |
Substance Name | PEMETREXED MONOHYDRATE |
Labeler Name | Eagle Pharmaceuticals, Inc. |
Pharmaceutical Class | Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA209472 |
Listing Certified Through | 2024-12-31 |
Package
NDC 42367-0531-33 (42367053133)
NDC Package Code | 42367-531-33 |
---|---|
Billing NDC | 42367053133 |
Package | 1 VIAL in 1 CARTON (42367-531-33) / 20 mL in 1 VIAL |
Marketing Start Date | 2022-02-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |